WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 370 | |
10 mg | In stock | $ 666 | |
20 mg | In stock | $ 999 | |
50 mg | In stock | $ 2203 | |
100 mg | In stock | $ 3480 |
Description | WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I). |
Targets&IC50 | Calu-3 (ERBB2 amp): 915 nM , H3255 (EGFR L858R): 66 nM, H1975 (EGFR L858R/T790M): 9 nM, HCC827 GR (EGFR E746_A750/MET amp): >3.3 μM, H1781 (ERBB2 Ins G776V, C): 744 nM , PC9 (EGFR Del E746_A750): 6 nM, PC9 GR (EGFR Del E746_A750/T790M): 8 nM, H1819 (ERBB2 amp): 738 nM , HCC827 (EGFR Del E746_A750): 1 nM |
In vitro | Cells are exposed to increasing concentrations of WZ8040 for 72 hours. Growth is assessed using the MTS survival assay.(Only for Reference) |
CAS No. | 1214265-57-2 |
Chemical Formula | C24H25ClN6OS |
Molecular Weight | 481.02 |
Solubility | H2O: <1 mg/mL Ethanol: 3 mg/mL (6.23 mM); DMSO: 89 mg/mL (185 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom